PRESS RELEASE published on 12/23/2024 at 12:30, 1 year 6 months ago Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone Zomedica launches two new assays for TRUFORMA Platform - canine NT-proBNP and progesterone tests for dogs. These assays provide precise in-clinic results for cardiac and reproductive conditions Zomedica TRUFORMA Platform NT-proBNP Test Canine Assays Progesterone Testing
BRIEF published on 12/19/2024 at 12:35, 1 year 6 months ago Zomedica nomme Scott A. Jordan au poste de nouveau directeur financier Direction Financière Zomedica Santé Animale Santé Vétérinaire Scott A. Jordan
BRIEF published on 12/19/2024 at 12:35, 1 year 6 months ago Zomedica Names Scott A. Jordan as New CFO Zomedica Veterinary Health Animal Health Finance Leadership Scott A. Jordan
PRESS RELEASE published on 12/19/2024 at 12:30, 1 year 6 months ago Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Zomedica appoints seasoned executive Scott A. Jordan as EVP Finance and CFO, bringing 30 years of industry experience. CEO Larry Heaton welcomes him to the leadership team Zomedica Leadership Team Animal Health Executive Scott A. Jordan
BRIEF published on 11/27/2024 at 12:35, 1 year 6 months ago Zomedica to Showcase at NobleCon20 Equity Conference Investor Conference Zomedica Veterinary Health Equity Growth NobleCon20
BRIEF published on 11/27/2024 at 12:35, 1 year 6 months ago Zomedica sera présenté à la conférence sur les actions NobleCon20 Zomedica Santé Vétérinaire Conférence Des Investisseurs Croissance Des Capitaux Propres NobleCon20
PRESS RELEASE published on 11/27/2024 at 12:30, 1 year 6 months ago Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 Zomedica Corp. CEO Larry Heaton to present and host meetings with investors at NobleCon20. Company offers veterinary health solutions for animals Zomedica Corp. Veterinary Health Larry Heaton Animal Healthcare NobleCon20
BRIEF published on 11/14/2024 at 12:35, 1 year 7 months ago Zomedica Launches Equine Insulin Assay on TRUFORMA Platform Zomedica Veterinary Diagnostics TRUFORMA Platform Equine Health Equine Insulin Assay
BRIEF published on 11/14/2024 at 12:35, 1 year 7 months ago Zomedica lance un test d'insuline équine sur la plateforme TRUFORMA Zomedica Diagnostic Vétérinaire Plateforme TRUFORMA Dosage De L'insuline Équine Santé Équine
PRESS RELEASE published on 11/14/2024 at 12:30, 1 year 7 months ago Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform Zomedica launches TRUFORMA Insulin assay for equine plasma, providing rapid results in 18 minutes for diagnosing and monitoring insulin levels in horses, aiding in treatment decisions for equine metabolic syndrome and PPID Zomedica TRUFORMA Insulin Assay Equine Plasma Horse Healthcare
Published on 06/26/2026 at 01:40, 7 hours 23 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 9 hours 33 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 10 hours 33 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 11 hours 31 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 17 hours 33 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 08:00, 1 hour 3 minutes ago MHM Corporate: Debt Restructuring through Bonds Redeemable in Shares
Published on 06/26/2026 at 08:00, 1 hour 3 minutes ago MHM Corporate: Restructuration de sa dette par voie d'obligations remboursables en actions
Published on 06/26/2026 at 07:30, 1 hour 33 minutes ago REINET INVESTMENTS S.C.A. ANNOUNCES REVISED DATE FOR ANNUAL GENERAL MEETING
Published on 06/26/2026 at 07:30, 1 hour 33 minutes ago THE NAGA GROUP AG CONFIRMS FY 2025 REVENUES AND REPORTS STRONGER-THAN-EXPECTED EBITDA
Published on 06/26/2026 at 07:00, 2 hours 3 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 2 hours 3 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 14 hours 18 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 14 hours 33 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 15 hours 13 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS